(Q36898693)

17 August 2017

1 reference

title

Evaluation and management of obesity-related nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

17 August 2017

0 references

1 reference

Clare Nugent

1

1 reference

PubMed ID

17667992

17 August 2017

Zobair M Younossi

series ordinal

2

1 reference

PubMed ID

17667992

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Nature Reviews Gastroenterology & Hepatology

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

432-441

1 reference

17 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpgasthep0879

17 August 2017

0 references

cites work

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

Diabetic ketoacidosis secondary to growth hormone treatment in a boy with Prader-Willi syndrome and steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

Chronological development of elevated aminotransferases in a nonalcoholic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Is NASH underdiagnosed among African Americans?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Hepatic histology in obese patients undergoing bariatric surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic fatty liver disease (NAFLD) two decades later: are we smarter about its natural history?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Cryptogenic cirrhosis and NAFLD: are they related?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Non-alcoholic steatohepatitis and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Screening in liver disease: report of an AASLD clinical workshop

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Non-alcoholic fatty liver disease in a toddler

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Prevalence of fatty liver in children and adolescents.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Non-alcoholic steatohepatitis in children

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Pathogenesis of NASH: animal models

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Cytokines and the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Metabolic syndrome and NASH.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic fatty liver disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Fatty infiltration of liver in hyperlipidemic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

The assessment of insulin resistance in man.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Role of radiologic modalities in the management of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Quantitative evaluation of fatty liver by computed tomography in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Quantification of liver fat using magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Diagnosis of NASH using delayed parenchymal imaging of contrast ultrasound

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Hepatic effects of dietary weight loss in morbidly obese subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Persistent hyperaminotransferasemia resolving after weight reduction in obese children.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Regression of hepatic steatosis in morbidly obese persons after gastric bypass

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0879

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0879

1 reference

17 August 2017

1 reference

PubMed ID

17667992